Immunogenicity, Tolerability, and Clinical Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine in Patients with Systemic Lupus Erythematosus

The aim of the work is to study the immunogenicity, tolerability, and clinical efficacy of the 23-valent polysaccharide pneumococcal vaccine (PPV-23) in patients with systemic lupus erythematosus (SLE). Material and methods. The study included 61 patients with a confirmed diagnosis of SLE, including...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	G. M. Tarasova, B. S. Belov, M. V. Cherkasova, S. K. Soloviev, E. A. Aseeva, T. M. Reshetnyak, T. V. Popkova, N. M. Kosheleva
Format:	Artigo
Sprog:	Russo
Udgivet:	LLC "Publishing House OKI" 2020-08-01
Serier:	Антибиотики и Химиотерапия
Fag:	systemic lupus erythematosus pneumonia vaccination 23-valent polysaccharide pneumococcal vaccine immunosuppressive therapy genetically engineered biological drugs
Online adgang:	https://www.antibiotics-chemotherapy.ru/jour/article/view/738
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!